Summary:
The management of uterine bleeding in female transplant patients over a 3-year period at our institution was reviewed. A total of 33 females who had undergone allogeneic hematopoietic stem cell transplant were identified as having received gynecologic consultation for the diagnosis of menorrhagia. Hormone therapy achieved a resolution of symptoms in 32 (97%) of the patients, and 26 (79%) required only one hormone regimen. Following resolution of symptoms, transition to standard-dose oral contraceptive pills as maintenance therapy prevented recurrent menorrhagia due to high circulating estrogen levels. Alternatives for patients who are unable to tolerate oral administration and those with hepatotoxicity are also discussed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dowsett M, Richner J . Effects of cytotoxic chemotherapy on ovarian and adrenal steroidogenesis in premenopausal breast cancer patients. Oncology 1991; 48: 215–220.
Sanders JE, Buckner CD, Leonard JM et al. Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation 1983; 36: 252–255.
Rosenfeld JA . Treatment of menorrhagia due to dysfunctional uterine bleeding. Am Fam Physician 1996; 53: 165–172.
Irvine GA . Medical management of dysfunctional uterine bleeding. Baillière's Clin Obstet Gynecol 1999; 13: 189–202.
Munro MG . Dysfunctional uterine bleeding: advances in diagnosis and treatment. Curr Opin Obstet Gynecol 2001; 13: 475–489.
Reich H, Ribeiro SC, Vidali A . Hysterectomy as treatment for dysfunctional uterine bleeding. Best Pract Res Clin Obstet Gynecol 1999; 13: 251–269.
Laufer MR, Townsend NL, Parsons KE et al. Inducing amenorrhea during bone marrow transplantation. A pilot study of leuprolide acetate. J Reprod Med 1997; 42: 537–541.
Ghalie R, Porter C, Radwanska E et al. Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation. Am J Hematol 1993; 42: 350–353.
Chiusolo P, Salutari P, Sica S et al. Lutenizing hormone-releasing hormone analogue: leuprorelin acetate for the prevention of menstrual bleeding in premenopausal women undergoing stem cell transplantation. Bone Marrow Transplant 1998; 21: 821–823.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Amsterdam, A., Jakubowski, A., Castro-Malaspina, H. et al. Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 34, 363–366 (2004). https://doi.org/10.1038/sj.bmt.1704577
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704577
Keywords
This article is cited by
-
Gynecologic Issues in the Pediatric and Adolescent Patient with Cancer
Current Treatment Options in Pediatrics (2016)
-
The treatment of menorrhagia in female stem cell transplant recipients
Bone Marrow Transplantation (2005)